학술논문

Combination of aging and dimethylhydrazine treatment causes an increase in cancer - stem cell population of rat colonic crypts
Document Type
Report
Source
Biochemical and Biophysical Research Communications. July 31, 2009, Vol. 385 Issue 3, p430, 4 p.
Subject
Cancer -- Health aspects
Cancer -- Statistics
Oncology, Experimental -- Health aspects
Oncology, Experimental -- Statistics
Colon cancer -- Health aspects
Colon cancer -- Statistics
Stem cells -- Health aspects
Stem cells -- Statistics
Cancer -- Research
Cancer -- Care and treatment
Language
English
ISSN
0006-291X
Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.bbrc.2009.05.080 Byline: Edi Levi (a)(d), Sandhya Misra (c), Jianhua Du (a)(c), Bhaumik B. Patel (a)(b), Adhip P.N. Majumdar (a)(b)(c) Keywords: Aging; Cancer stem cells; Colon cancer; Dimethylhydrazine; CD166; ALDH1 Abstract: Aging is associated with increased incidence of colon cancers. It is also becoming evident that cancer stem cells (CSC) play a vital role in the pathogenesis and prognosis of colon cancer. Recently, we reported the presence of colon cancer stem-like cells in macroscopically normal mucosa in patients with adenomatous polyps and that they increase with aging, suggesting that aging may predispose the colon to carcinogenesis. In the current study we have examined the combined effects of aging and carcinogen exposure on the status of colon CSCs in an experimental model. We used young (4-6months) and aged (22-24months) rats and exposed them to the carcinogen, dimethylhydroxide (DMH). We investigated the expression of colon cancer stem cell markers, CD44, CD166, EpCam, and ALDH1 as well as EGFR expression in normal colonic crypt epithelium following carcinogen treatment. Our results demonstrate that aging per se or carcinogen treatment alone causes an increase in the number of colon cancer stems cells, as evidenced by increased immunoreactive-CSC-markers positive cells in the colonic mucosa. In aged rats, carcinogen exposure results in a more pronounced increase in colon cancer stem cells. Our study shows that in aging colon the effects of carcinogens are more pronounced, and an increase in colon CSCs is one of the earliest changes preceding tumor development. Moreover, the current investigation of the use of a panel of immunohistochemical markers of colon CSC can potentially serve as a prognostic marker during screening for colon cancer. Author Affiliation: (a) Department of Veterans Affairs Medical Center, Wayne State University, Detroit, MI 48201, USA (b) Karmanos Cancer Center, Wayne State University, Detroit, MI 48201, USA (c) Department of Internal Medicine, Wayne State University, Detroit, MI 48201, USA (d) Department of Pathology, Wayne State University, Detroit, MI 48201, USA Article History: Received 13 May 2009